Skip to main content
Watch Insiders
CMMBHealthcare

Chemomab Therapeutics Ltd ADR (CMMB) Insider Trading

In the last 90 days, 1 Chemomab Therapeutics Ltd ADR (CMMB) insider reported no open-market purchases and 1 sale totaling $6,516. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Aug 28, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Aug 28, 2026Neil Harris CohenCorporate insiderSale2,304$2.83$6,516
May 29, 2026George Adi MorChief Executive OfficerOpen Market Purchase9,804$2.07$20,246

Common questions

CMMB insider trading FAQ

Are CMMB insiders buying or selling?
Over the last 90 days, CMMB insiders were net sellers, reporting $0.00 of open-market purchases and $6,516 of sales.
When was the last CMMB insider purchase?
No open-market insider purchase of Chemomab Therapeutics Ltd ADR stock was reported in the last 90 days.
Where does CMMB insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Chemomab Therapeutics Ltd ADR officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.